Deltex Historical Cash Flow
| DEMG Stock | 0.08 0.01 6.67% |
Analysis of Deltex Medical cash flow over time is an excellent tool to project Deltex Medical Group future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 856.3 K or Depreciation of 152.9 K as it is a great indicator of Deltex Medical ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Deltex Medical Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Deltex Medical Group is a good buy for the upcoming year.
Deltex |
About Deltex Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Deltex balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Deltex's non-liquid assets can be easily converted into cash.
Deltex Medical Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Deltex Medical Group to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Deltex Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Deltex Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Deltex Medical Group current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Deltex Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Deltex Medical's Change To Liabilities is comparatively stable compared to the past year.
Deltex Medical cash flow statement Correlations
Click cells to compare fundamentals
Deltex Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Deltex Medical cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (235K) | 13K | 89K | (48K) | 105K | 110.3K | |
| Change In Cash | 328K | (55K) | (440K) | 58K | 234K | 245.7K | |
| Free Cash Flow | 349K | (239K) | (935K) | (1.4M) | (1.6M) | (1.6M) | |
| Change In Working Capital | 410K | 379K | 434K | 208K | (232K) | (220.4K) | |
| Begin Period Cash Flow | 580K | 908K | 853K | 413K | 471K | 856.3K | |
| Other Cashflows From Financing Activities | (33K) | (40K) | 543K | (160K) | (245K) | (232.8K) | |
| Depreciation | 233K | 143K | 114K | 128K | 133K | 152.9K | |
| Other Non Cash Items | 189K | 104K | (72K) | 262K | 161K | 169.1K | |
| Capital Expenditures | 260K | 171K | 644K | 744K | 370K | 293.0K | |
| Total Cash From Operating Activities | 609K | (68K) | (291K) | (606K) | (1.2M) | (1.3M) | |
| Net Income | (161K) | (798K) | (967K) | (1.1M) | (1.3M) | (1.3M) | |
| Total Cash From Financing Activities | (67K) | 190K | 502K | 1.4M | 1.8M | 1.4M | |
| End Period Cash Flow | 908K | 853K | 413K | 471K | 705K | 780.0K | |
| Change To Account Receivables | 427K | 680K | 148K | (57K) | 332K | 234.2K | |
| Stock Based Compensation | 166K | 117K | 39K | 95K | 125K | 0.0 | |
| Sale Purchase Of Stock | 952K | 2.2M | 322K | 253K | 227.7K | 216.3K | |
| Net Borrowings | (389K) | (60K) | 502K | 188K | 216.2K | 227.0K | |
| Total Cashflows From Investing Activities | (201K) | (171K) | (644K) | (744K) | (855.6K) | (898.4K) | |
| Change To Operating Activities | (1K) | 6K | (11K) | 7K | 8.1K | 8.5K | |
| Change To Netincome | 125K | 195K | 127K | 203K | 182.7K | 149.0K | |
| Change To Liabilities | 212K | (303K) | 191K | 306K | 275.4K | 289.2K | |
| Investments | (201K) | (171K) | (644K) | (744K) | (370K) | (388.5K) | |
| Issuance Of Capital Stock | 322K | 253K | 0.0 | 1.3M | 1.9M | 1.1M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Deltex Stock Analysis
When running Deltex Medical's price analysis, check to measure Deltex Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Deltex Medical is operating at the current time. Most of Deltex Medical's value examination focuses on studying past and present price action to predict the probability of Deltex Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Deltex Medical's price. Additionally, you may evaluate how the addition of Deltex Medical to your portfolios can decrease your overall portfolio volatility.